Answers are grounded in this paper and cite their sources.
Demonstrates enhanced tumor therapy through multidimensional calcium overload modulation.
Disruption of calcium ion (Ca 2+ ) homeostasis has emerged as a promising strategy for tumor therapy. However, the intricate regulation of Ca 2+ signaling and the limitations of single-dimensional modulation often hinder therapeutic efficacy. Here, we developed a Janus nanomotor platform that orchestrates mechanochemically coupled multidimensional modulation of Ca 2+ overload for enhanced tumor therapy. Utilizing a liquid–nano–liquid interface-mediated anisotropic encapsulation strategy, amorphous calcium carbonate (ACC) nanoparticles were asymmetrically coated with mesoporous polydopamine (mPDA) and subsequently functionalized with l -arginine ( l -Arg) and hyaluronic acid (HA), forming the Janus ACC@SiO 2 &mPDA-Arg-HA nanomotors that combine structural asymmetry, NO-driven propulsion, and tumor-targeting capability. Within the tumor microenvironment (TME), degradation of the ACC provided a sustained exogenous Ca 2+ reservoir. Simultaneously, the endogenous catalytic conversion of l -Arg into NO triggered self-propulsion, mechanically stimulating the cell membrane to activate Piezo1 channels and promote extracellular Ca 2+ influx. In parallel, NO acted as a gaseous chemical messenger to trigger ryanodine receptors (RyRs)-mediated Ca 2+ release from the endoplasmic reticulum (ER). The mechanically and chemically coupled regulation induces persistent Ca 2+ overload, leading to mitochondrial dysfunction and apoptosis. Our study presents a paradigm of mechanochemical coupling for multidimensional signal modulation, offering a framework for engineering nanomachines that reprogram intracellular signaling in cancer therapy.
No takes yet. Share an insight, caveat, or question.
Zhan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: